Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BTB domain containing 10 pseudogene 1 (BTBD10P1) is a classified pseudogene, meaning it is a DNA sequence that is similar to a known protein-coding gene (in this case, likely similar to BTB domain containing 10, or BTBD10), but contains mutations or deletions that prevent it from coding a functional protein[4]. There is currently no evidence that BTBD10P1 encodes a functional receptor, enzyme, or other canonical therapeutic target. By definition, pseudogenes may sometimes produce non-coding transcripts that regulate their "parent" genes through RNA mechanisms—acting as competitive endogenous RNAs or so-called "miRNA decoys"—though this behavior is well-established only for specific pseudogenes such as PTENP1 and not specifically for BTBD10P1[1][7]. There are no established biological or disease roles, drug interactions, or uses as a biomarker or therapeutic target for BTBD10P1. The BTB/POZ domain is a protein–protein interaction motif found in many transcriptional regulators; the parent gene BTBD10 (not the pseudogene) has some published functional biology[2][3]. The "P1" suffix denotes a pseudogene; such loci are typically non-coding[4]. There is no evidence that BTBD10P1 encodes a protein or has therapeutic target status. Pseudogenes as a class have received interest for potential regulatory and disease relevance, but BTBD10P1 is not established in this way[1][7]. BTBD10P1 is a non-coding pseudogene, not a validated therapeutic target, receptor, or protein-coding gene. No interacting drugs, mechanism of action, biomarkers, or disease involvement is known for this locus at present[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BTB domain containing 10 pseudogene 1 (BTBD10P1).